Structured follow-up after pulmonary embolism
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests a structured follow-up program for people who have had a pulmonary embolism. The program aims to help you recover better after your clot and lower the chance of future problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a pulmonary embolism (blood clot in the lung) confirmed by a CT scan.
- You live in Denmark.
- You do not have an active cancer diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how people do after an acute pulmonary embolism (a blood clot in the lungs). It aims to understand real-world outcomes over follow-up and may help improve how care teams track patients after treatment.
This trial studies a structured pulmonary (lung) rehabilitation program for people who still have breathing and activity problems after a pulmonary embolism (PE). It may help improve physical ability and function during recovery.
This study records information about people who have had a pulmonary embolism, so researchers can learn how patients do over time. It may help improve understanding of outcomes and care patterns for future patients.
This study follows people who had a serious blood clot in their lungs that also affected their heart's right side. It tests how their ability to walk and move changes over 6 months, helping doctors understand recovery better.
This study tracks how patients do long-term after having a clot in the lung treated with a device called the Indigo Aspiration System. It aims to better understand safety and outcomes over time.
This study uses heart signals and blood tests to predict how well your heart will recover over a year after a pulmonary embolism. It may help doctors tailor your care based on your personal risk.
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.